Search by Drug Name or NDC
NDC 36800-0675-20 EXTRA STRENGHT HEADACHE RELIEF 250; 250; 65 mg/1; mg/1; mg/1 Details
EXTRA STRENGHT HEADACHE RELIEF 250; 250; 65 mg/1; mg/1; mg/1
EXTRA STRENGHT HEADACHE RELIEF is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by TOPCO ASSOCIATES LLC. The primary component is ACETAMINOPHEN; ASPIRIN; CAFFEINE.
Product Information
| NDC | 36800-0675 |
|---|---|
| Product ID | 36800-675_0c0702c2-b281-597b-e063-6294a90a8663 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | EXTRA STRENGHT HEADACHE RELIEF |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ACETAMINOPHEN, ASPIRIN, CAFFEINE |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 250; 250; 65 |
| Active Ingredient Units | mg/1; mg/1; mg/1 |
| Substance Name | ACETAMINOPHEN; ASPIRIN; CAFFEINE |
| Labeler Name | TOPCO ASSOCIATES LLC |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [E |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M013 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 36800-0675-20 (36800067520)
| NDC Package Code | 36800-675-20 |
|---|---|
| Billing NDC | 36800067520 |
| Package | 2 BOTTLE in 1 CARTON (36800-675-20) / 100 TABLET in 1 BOTTLE (36800-675-10) |
| Marketing Start Date | 2020-10-28 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |